DK0572942T4 - Orale farmaceutiske præparater til specifik frigivelse i kolon - Google Patents
Orale farmaceutiske præparater til specifik frigivelse i kolonInfo
- Publication number
- DK0572942T4 DK0572942T4 DK93108658T DK93108658T DK0572942T4 DK 0572942 T4 DK0572942 T4 DK 0572942T4 DK 93108658 T DK93108658 T DK 93108658T DK 93108658 T DK93108658 T DK 93108658T DK 0572942 T4 DK0572942 T4 DK 0572942T4
- Authority
- DK
- Denmark
- Prior art keywords
- oral pharmaceutical
- colon
- pharmaceutical preparations
- specific release
- core
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4891—Coated capsules; Multilayered drug free capsule shells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921347A IT1260505B (it) | 1992-06-01 | 1992-06-01 | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
Publications (2)
Publication Number | Publication Date |
---|---|
DK0572942T3 DK0572942T3 (da) | 1997-10-20 |
DK0572942T4 true DK0572942T4 (da) | 2001-01-22 |
Family
ID=11363431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK93108658T DK0572942T4 (da) | 1992-06-01 | 1993-05-28 | Orale farmaceutiske præparater til specifik frigivelse i kolon |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0572942B2 (it) |
AT (1) | ATE151285T1 (it) |
DE (1) | DE69309540T3 (it) |
DK (1) | DK0572942T4 (it) |
ES (1) | ES2101164T5 (it) |
GR (2) | GR3023605T3 (it) |
HU (1) | HUT75158A (it) |
IT (1) | IT1260505B (it) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6764697B1 (en) | 1991-06-27 | 2004-07-20 | Alza Corporation | System for delaying drug delivery up to seven hours |
US5686105A (en) * | 1993-10-19 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
US5436011A (en) * | 1993-04-16 | 1995-07-25 | Bristol-Myers Squibb Company | Solid pharmaceutical dosage form and a method for reducing abrasion |
ES2068762B1 (es) * | 1993-07-21 | 1995-12-01 | Lipotec Sa | Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion. |
US5482718A (en) * | 1994-03-23 | 1996-01-09 | Hoffmann-La Roche Inc. | Colon-targeted delivery system |
US5686106A (en) * | 1995-05-17 | 1997-11-11 | The Procter & Gamble Company | Pharmaceutical dosage form for colonic delivery |
US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
US5766629A (en) * | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
GB9620709D0 (en) * | 1996-10-04 | 1996-11-20 | Danbiosyst Uk | Colonic delivery of weak acid drugs |
US5891474A (en) * | 1997-01-29 | 1999-04-06 | Poli Industria Chimica, S.P.A. | Time-specific controlled release dosage formulations and method of preparing same |
US5788987A (en) * | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
NL1009107C2 (nl) | 1997-11-12 | 1999-06-15 | Banner Pharmacaps Inc | Gelatine-uitspreidende doos met meervoudige, aanpasbare poortklep en meerlagig zacht gel. |
US6531152B1 (en) | 1998-09-30 | 2003-03-11 | Dexcel Pharma Technologies Ltd. | Immediate release gastrointestinal drug delivery system |
UA74141C2 (uk) | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
US6632451B2 (en) | 1999-06-04 | 2003-10-14 | Dexcel Pharma Technologies Ltd. | Delayed total release two pulse gastrointestinal drug delivery system |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
IL157634A0 (en) | 2001-03-13 | 2004-03-28 | Penwest Pharmaceuticals Co | Chronotherapeutic dosage forms containing glucocorticosteroid |
FR2830446B1 (fr) * | 2001-10-09 | 2004-02-06 | Univ Pasteur | Composition pharmaceutique destinee a liberer une substance active au niveau du colon |
JP2006507298A (ja) * | 2002-10-30 | 2006-03-02 | ファルマシア コーポレーション | 経口持続放出型錠剤、ならびにその製造法および使用法 |
CU23334A1 (es) * | 2003-03-20 | 2008-12-24 | Inst Finlay | Vacuna de vibrio cholerae inactivada en tabletas |
KR100782918B1 (ko) | 2003-09-19 | 2007-12-07 | 펜웨스트 파머슈티칼즈 컴파니 | 지연 방출성 제형 |
GB2411355B (en) | 2004-02-27 | 2006-02-22 | Niche Generics Ltd | Pharmaceutical composition |
ITMI20041295A1 (it) * | 2004-06-25 | 2004-09-25 | Cosmo Spa | Composizioni farmaceutiche antimicrobiche orali |
EP1754471A1 (de) * | 2005-08-18 | 2007-02-21 | ORAMON-Arzneimittel GmbH & Co. KG | Verwendung einer quellbaren Zwischenschicht zur Steuerung des Freisetzungsprofils einer festen Arzneimittelformulierung zur peroralen Anwendung und diese enthaltende Arzneimittelformulierung |
GB0600928D0 (en) | 2006-01-17 | 2006-02-22 | Novacta Biosystems Ltd | Improvements relating to lantibiotics |
GB0714030D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | The use of type-B lantibiotic-based compounds having antimicrobial activity |
GB0714029D0 (en) | 2007-07-18 | 2007-08-29 | Novacta Biosystems Ltd | Lantibiotic-based compounds having antimicrobial activity |
CN102105140B (zh) * | 2008-07-02 | 2013-10-23 | 巴斯夫欧洲公司 | 涂覆片剂的方法 |
IT1393244B1 (it) | 2008-07-18 | 2012-04-12 | Universita' Degli Studi Di Milano | Sistema per il rilascio al colon di farmaci suscettibili di degradazione enzimatica e/o scarsamente assorbiti nel tratto gastrointestinale |
MX2011007313A (es) | 2009-01-14 | 2011-08-04 | Novacta Biosystems Ltd | Derivados de desoxiactagardina. |
SG173504A1 (en) | 2009-02-04 | 2011-09-29 | Novacta Biosystems Ltd | Actagardine derivatives |
WO2015161139A1 (en) | 2014-04-16 | 2015-10-22 | Rapamycin Holdings, Llc | Oral rapamycin preparation and use for stomatitis |
GB201001688D0 (en) | 2010-02-02 | 2010-03-17 | Novacta Biosystems Ltd | Compounds |
WO2012013495A1 (en) | 2010-07-29 | 2012-02-02 | Cosmo Technologies Ltd. | Pharmaceutical and/or dietary compositions based on short chain fatty acids |
GB201013513D0 (en) | 2010-08-11 | 2010-09-22 | Novacta Biosystems Ltd | Formulations |
WO2013003697A1 (en) | 2011-06-30 | 2013-01-03 | Trustees Of Boston University | Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1) |
JP6049938B2 (ja) | 2013-04-05 | 2016-12-21 | ポリケム・エスエイ | 過敏腸管症候群を治療するためのピドチモドの使用 |
CA3206208A1 (en) | 2013-12-31 | 2015-07-09 | Rapamycin Holdings, Llc | Oral rapamycin nanoparticle preparations and use |
CN105943505A (zh) * | 2016-05-26 | 2016-09-21 | 杭州百诚医药科技股份有限公司 | 一种匹多莫德药物组合物及其制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4891223A (en) * | 1987-09-03 | 1990-01-02 | Air Products And Chemicals, Inc. | Controlled release delivery coating formulation for bioactive substances |
IT1230576B (it) * | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
US5032406A (en) † | 1989-02-21 | 1991-07-16 | Norwich Eaton Pharmaceuticals, Inc. | Dual-action tablet |
PH27186A (en) * | 1989-09-07 | 1993-04-16 | Ciba Geigy Ag | Double-coated granules of disodium pamidronate |
DK469989D0 (da) † | 1989-09-22 | 1989-09-22 | Bukh Meditec | Farmaceutisk praeparat |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
-
1992
- 1992-06-01 IT ITMI921347A patent/IT1260505B/it active IP Right Grant
-
1993
- 1993-05-28 EP EP93108658A patent/EP0572942B2/en not_active Expired - Lifetime
- 1993-05-28 DE DE69309540T patent/DE69309540T3/de not_active Expired - Lifetime
- 1993-05-28 AT AT93108658T patent/ATE151285T1/de active
- 1993-05-28 HU HU9301577A patent/HUT75158A/hu unknown
- 1993-05-28 ES ES93108658T patent/ES2101164T5/es not_active Expired - Lifetime
- 1993-05-28 DK DK93108658T patent/DK0572942T4/da active
-
1997
- 1997-05-30 GR GR970401249T patent/GR3023605T3/el unknown
-
2001
- 2001-02-14 GR GR20010400245T patent/GR3035415T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0572942T3 (da) | 1997-10-20 |
ITMI921347A1 (it) | 1993-12-02 |
DE69309540D1 (de) | 1997-05-15 |
IT1260505B (it) | 1996-04-09 |
EP0572942A2 (en) | 1993-12-08 |
ES2101164T5 (es) | 2001-02-01 |
ATE151285T1 (de) | 1997-04-15 |
GR3035415T3 (en) | 2001-05-31 |
EP0572942B2 (en) | 2000-11-29 |
HU9301577D0 (en) | 1993-09-28 |
DE69309540T3 (de) | 2001-03-15 |
ITMI921347A0 (it) | 1992-06-01 |
HUT75158A (en) | 1997-04-28 |
EP0572942A3 (en) | 1994-08-24 |
ES2101164T3 (es) | 1997-07-01 |
GR3023605T3 (en) | 1997-08-29 |
EP0572942B1 (en) | 1997-04-09 |
DE69309540T2 (de) | 1997-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0572942T4 (da) | Orale farmaceutiske præparater til specifik frigivelse i kolon | |
ATE9695T1 (de) | Antihistamine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE69923200D1 (de) | Neue oral anzuwendende arzneizubereitungen für rivastigmine mit kontrollierter wirkstoffabgabe | |
FI933248A0 (fi) | Optiskt aktiva 5h-pyrrolo(3,4-b)pyrazinderat, dess framstaellning och farmaceutiska kompositioner innehaollande detta | |
FI913248A (fi) | Kontrollerat frigoerande fast farmaceutisk doseringsform. | |
ITBO910113A1 (it) | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. | |
ATE235507T1 (de) | Neue aminosäurederivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen | |
DK1063995T3 (da) | Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator | |
DE68909412D1 (de) | Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. | |
NO942952D0 (no) | 11-benzaldoksin-17 ater, fremgangsmåte for deres fremstilling samt legemiddel inneholdende slike | |
ITFI930030A0 (it) | Composti pirrol-amidinici, e loro sali farmaceuticamente accettabili, processi di preparazione e composizione farmaceutiche che li contengo-no. | |
NO884005L (no) | Fluorerte derivater av aminosyrer saerlig for bruk som overflateaktive midler. | |
AR002191A1 (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion, procedimiento para su preparacion | |
DK183582A (da) | Fremgangsmaade til fremstilling af oxazolderivater | |
DE69104608D1 (de) | Pharmazeutische Zubereitungen, Clavulansäure enthaltend, für die Behandlung der Periodontitis. | |
FI822671L (fi) | Aminoglykosidderivat, foerfaranden foer framstaellning av dem, farmaceutiska kompositioner innehaollande dem samt anvaendning av saodana derivat som laekemedel | |
DK11089A (da) | 2,5-diazabicyclooe2.2.1aaheptan-forbindelser, deres anvendelse til fremstilling af antiarytmi-laegemidler, farmaceutiske praeparater indeholdende forbindelserne samt forbindelse til anvendelse som udgangsmateriale ved deres fremstilling | |
ATE59551T1 (de) | Feste orale arzneiformen mit gestaffelter wirkung zur verabreichung von wirkstoffen mit geschwuere erzeugender nebenwirkung. | |
NO961429D0 (no) | Fremgangsmåte for fremstilling av kinolonholdige, orale preparater | |
ES2127305T3 (es) | Una forma farmaceutica para la administracion rectal de compuestos farmacologicamente activos. | |
JPS51148017A (en) | Controlling agents for slime | |
JPS5253830A (en) | Preparation of optically active benzyl alcohol derivatives | |
ATE10934T1 (de) | Peptid, verfahren zu dessen herstellung und dessen verwendung. | |
ATE2673T1 (de) | Phenothiazinderivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung. | |
DE423151T1 (de) | Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen. |